{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T14:33:22Z","timestamp":1774794802615,"version":"3.50.1"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.jinf.2015.04.023","type":"journal-article","created":{"date-parts":[[2015,4,24]],"date-time":"2015-04-24T21:31:13Z","timestamp":1429911073000},"page":"S121-S125","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"S1","title":["Azole-resistant aspergillosis"],"prefix":"10.1016","volume":"71","author":[{"given":"Adilia","family":"Warris","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2015.04.023_bib1","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1086\/595846","article-title":"Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of multicenter Prospective Antifungal Therapy (PATH) Alliance registry","volume":"48","author":"Neofytos","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2015.04.023_bib2","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1086\/525258","article-title":"Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America","volume":"46","author":"Walsh","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2015.04.023_bib3","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/bmt.2010.175","article-title":"European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL3 2009 update","volume":"46","author":"Maertens","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jinf.2015.04.023_bib4","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1093\/cid\/cit411","article-title":"Long-term antifungal treatment improves health status in patients with chronic pulmonary aspergillosis: a longitudinal analysis","volume":"57","author":"Al-Shair","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2015.04.023_bib5","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1111\/cea.12333","article-title":"Anitfungal treatment in allergic bronchopulmonary aspergillosis with and without cystic fibrosis: a systematic review","volume":"44","author":"Moreira","year":"2014","journal-title":"Clin Exp All"},{"key":"10.1016\/j.jinf.2015.04.023_bib6","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/cea.12141","article-title":"Allergic bronchopulmonary aspergillosis: review of the literature and proposal of new diagnostic and classification criteria","volume":"43","author":"Agarwal","year":"2013","journal-title":"Clin Exp Allerg"},{"key":"10.1016\/j.jinf.2015.04.023_bib7","doi-asserted-by":"crossref","first-page":"423","DOI":"10.3109\/02770903.2012.662568","article-title":"Voriconazole and posaconazole improve asthma severity in allergic bronchopulmonary aspergillosis and severe asthma with fungal sensitization","volume":"49","author":"Chishimba","year":"2012","journal-title":"J Asthma"},{"issue":"4","key":"10.1016\/j.jinf.2015.04.023_bib8","doi-asserted-by":"crossref","first-page":"e36077","DOI":"10.1371\/journal.pone.0036077","article-title":"Treatment of Aspergillus fumigatus in patients with cystic fibrosis: a randomized, placebo-controlled pilot study","volume":"7","author":"Aaron","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jinf.2015.04.023_bib9","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1056\/NEJMoa061094","article-title":"Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia","volume":"356","author":"Cornely","year":"2007","journal-title":"N Eng J Med"},{"key":"10.1016\/j.jinf.2015.04.023_bib10","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1056\/NEJMoa061098","article-title":"Posaconazole or fluconazole prophylaxis in servere graft-versus-host disease","volume":"356","author":"Ullmann","year":"2007","journal-title":"N Eng J Med"},{"key":"10.1016\/j.jinf.2015.04.023_bib11","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1056\/NEJMoa021931","article-title":"Itraconazole to prevent fungal infections in chronic granulomatous disease","volume":"348","author":"Gallin","year":"2003","journal-title":"N Eng J Med"},{"key":"10.1016\/j.jinf.2015.04.023_bib12","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1097\/INF.0b013e3182195808","article-title":"A twice daily posaconazole dosing algorithm for children with chronic granulomatous disease","volume":"30","author":"Welzen","year":"2011","journal-title":"Ped Infect Dis J"},{"key":"10.1016\/j.jinf.2015.04.023_bib13","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1128\/MMBR.00045-10","article-title":"Regulatory circuitry governing fungal development, drug resistance, and disease","volume":"75","author":"Shapiro","year":"2011","journal-title":"Microbiol Mol Biol Rev"},{"key":"10.1016\/j.jinf.2015.04.023_bib14","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S0966-842X(03)00117-3","article-title":"Antifungal agents: mechanisms of action","volume":"11","author":"Odds","year":"2003","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.jinf.2015.04.023_bib15","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.drup.2009.09.002","article-title":"Azole-resistance in Aspergillus proposed nomenclature and breakpoints","volume":"12","author":"Verweij","year":"2009","journal-title":"Drug Resist Update"},{"key":"10.1016\/j.jinf.2015.04.023_bib16","series-title":"Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; approved standard","author":"Clinical and Laboratory Standards Institute","year":"2008"},{"key":"10.1016\/j.jinf.2015.04.023_bib17","doi-asserted-by":"crossref","first-page":"E248","DOI":"10.1111\/j.1469-0691.2012.03890.x","article-title":"European Committee on Antimicrobial Susceptibility Testing Subcommittee on Antifungal Susceptibility Testing (EUCAST-AFST). EUCAST technical note on Aspergillus and amphotericin B, itraconazole, and posaconazole","volume":"18","author":"Arendrup","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jinf.2015.04.023_bib18","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.3109\/13693786.2010.499916","article-title":"Aspergillus species intrinsically resistant to antifungal agents","volume":"49","author":"van der Linden","year":"2011","journal-title":"Med Mycol"},{"key":"10.1016\/j.jinf.2015.04.023_bib19","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/1469-0691.12513","article-title":"Update on antifungal resistance in Aspergillus and Candida","volume":"20","author":"Arendrup","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jinf.2015.04.023_bib20","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1128\/AAC.41.6.1364","article-title":"Itraconazole resistance in Aspergillus fumigatus","volume":"41","author":"Denning","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2015.04.023_bib21","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1056\/NEJM200212263472618","article-title":"Multidrug resistance in Aspergillus fumigatus","volume":"347","author":"Warris","year":"2002","journal-title":"N Eng J Med"},{"key":"10.1016\/j.jinf.2015.04.023_bib22","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.3201\/eid1507.090043","article-title":"Frequency and evolution of azole resistance in Aspergillus fumigatus associated with treatment failure","volume":"15","author":"Howard","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jinf.2015.04.023_bib23","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/AAC.05088-11","article-title":"Rapid induction of multiple resistance mechanisms in Aspergillus fumigatus during azole therapy: a case study and review of the literature","volume":"56","author":"Camps","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2015.04.023_bib24","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1056\/NEJMc061720","article-title":"Multiple-triazole-resistant aspergillosis","volume":"356","author":"Verweij","year":"2007","journal-title":"N Eng J Med"},{"issue":"11","key":"10.1016\/j.jinf.2015.04.023_bib25","doi-asserted-by":"crossref","first-page":"e219","DOI":"10.1371\/journal.pmed.0050219","article-title":"Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism","volume":"5","author":"Snelders","year":"2008","journal-title":"PLoS Med"},{"key":"10.1016\/j.jinf.2015.04.023_bib26","doi-asserted-by":"crossref","first-page":"4465","DOI":"10.1128\/AAC.00185-11","article-title":"Azole resistance in Aspergillus fumigatus isolates from the ARTEMIS global surveillance study is primarily due to the TR\/L98H mutation in the cyp51A gene","volume":"55","author":"Lockhart","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2015.04.023_bib27","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/jac\/dkr443","article-title":"Isolation of multiple triazole-resistant Aspergillus fumigatus strains carrying the TR\/L98H mutations in the cyp51A gene in India","volume":"67","author":"Chowdhary","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2015.04.023_bib28","doi-asserted-by":"crossref","first-page":"832","DOI":"10.3201\/eid1905.130075","article-title":"Azole-resistant Aspergillus fumigatus, Iran","volume":"19","author":"Seyedmousavi","year":"2013","journal-title":"Emerg Infect Dis"},{"issue":"10","key":"10.1016\/j.jinf.2015.04.023_bib29","doi-asserted-by":"crossref","first-page":"e1003633","DOI":"10.1371\/journal.ppat.1003633","article-title":"Emergence of azole-resistant Aspergillus fumigatus strains due to agricultural azole use creates an increasing threat to human health","volume":"9","author":"Chowdhary","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jinf.2015.04.023_bib30","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/QCO.0000000000000005","article-title":"Azole resistance in Aspergillus fumigatus: a growing public health concern","volume":"26","author":"Vermeulen","year":"2013","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.jinf.2015.04.023_bib31","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S1473-3099(09)70265-8","article-title":"Azole resistance in Aspergillus fumigatus: a side-effect of environmental fungicide use?","volume":"9","author":"Verweij","year":"2009","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jinf.2015.04.023_bib32","doi-asserted-by":"crossref","first-page":"4053","DOI":"10.1128\/AEM.00231-09","article-title":"Possible environmental origin of resistance of Aspergillus fumigatus to medical triazoles","volume":"75","author":"Snelders","year":"2009","journal-title":"Appl Environ Microbiol"},{"issue":"3","key":"10.1016\/j.jinf.2015.04.023_bib33","doi-asserted-by":"crossref","first-page":"e31801","DOI":"10.1371\/journal.pone.0031801","article-title":"Triazole fungicides can induce cross-resistance to medical triazoles in Aspergillus fumigatus","volume":"7","author":"Snelders","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jinf.2015.04.023_bib34","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/cid\/cit320","article-title":"Aspergillosis due to voriconazole highly resistant Aspergillus fumigatus and recovery of genetically related resistant isolates from domiciles","volume":"57","author":"van der Linden","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2015.04.023_bib35","first-page":"17","article-title":"Azole-resistant Aspergillus fumigatus due to TR46\/Y121F\/T289A mutation emerging in Belgium","author":"Vermeulen","year":"2012","journal-title":"Euro Surveill"},{"key":"10.1016\/j.jinf.2015.04.023_bib36","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1093\/jac\/dkt397","article-title":"Azole-resistant Aspergillus fumigatus with the environmental TR46\/Y121F\/T289A mutation in India","volume":"69","author":"Chowdhary","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2015.04.023_bib37","series-title":"SCARE network. Prospective international surveillance of azole resistance in Aspergillus fumigatus: SCARE network. Abstract M-490. 51st International Conference on Antimicrobial Agents and Chemotherapy","first-page":"17","author":"Van der Linden","year":"2011"},{"key":"10.1016\/j.jinf.2015.04.023_bib38","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.3201\/eid1710.110226","article-title":"Clinical implications of azole resistance in Aspergillus fumigatus","volume":"17","author":"van der Linden","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jinf.2015.04.023_bib39","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1086\/597465","article-title":"Azole-resistant central nervous system aspergillosis","volume":"48","author":"van der Linden","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2015.04.023_bib40","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1439-0507.2007.01345.x","article-title":"Poor efficacy of amphotericin B-based therapy in CNS aspergillosis","volume":"50","author":"Schwartz","year":"2007","journal-title":"Mycoses"},{"key":"10.1016\/j.jinf.2015.04.023_bib41","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1182\/blood-2005-02-0733","article-title":"Improved outcome in central nervous system aspergillosis using voriconazole treatment","volume":"106","author":"Schwartz","year":"2005","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.jinf.2015.04.023_bib42","doi-asserted-by":"crossref","first-page":"e10080","DOI":"10.1371\/journal.pone.0010080","article-title":"Development of azole resistance in Aspergillus fumigatus during azole therapy associated with change in virulence","volume":"5","author":"Arendrup","year":"2010","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.jinf.2015.04.023_bib43","doi-asserted-by":"crossref","first-page":"e72280","DOI":"10.1371\/journal.pone.0072280","article-title":"Composite survival index to compare virulence changes in azole-resistant Aspergillus fumigatus clinical isolates","volume":"8","author":"Mavridou","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jinf.2015.04.023_bib44","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1093\/cid\/cir179","article-title":"High-frequency triazole resistance found in nonculturable Aspergillus fumigatus from lungs of patients with chronic fungal disease","volume":"52","author":"Denning","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2015.04.023_bib45","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1128\/JCM.02221-09","article-title":"Rapid diagnosis of azole-resistant aspergillosis by direct PCR using tissue specimens","volume":"48","author":"van der Linden","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jinf.2015.04.023_bib46","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1128\/AAC.02226-12","article-title":"Pharmacodynamics and dose-response relationships of liposomal amphotericin B against different azole-resistant Aspergillus fumigatus isolates in a murine model of disseminated aspergillosis","volume":"57","author":"Seyedmousavi","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2015.04.023_bib47","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/jac\/dks402","article-title":"Efficacy and pharmacodynamics of voriconazole combined with anidulafungin in azole-resistant invasive aspergillosis","volume":"68","author":"Seyedmousavi","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2015.04.023_bib48","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1128\/AAC.02226-12","article-title":"In\u00a0vitro interaction of voriconazole and anidulafungin against triazole-resistant Aspergillus fumigatus","volume":"57","author":"Seyedmousavi","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2015.04.023_bib49","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1056\/NEJMoa020191","article-title":"Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis","volume":"347","author":"Herbrecht","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jinf.2015.04.023_bib50","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1086\/514341","article-title":"Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high loading dose regimen with standard dosing (AmBiLoad trial)","volume":"44","author":"Cornely","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2015.04.023_bib51","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1093\/jac\/dkp355","article-title":"An EORTC Phase II study of caspofungin as first-line therapy of invasive aspergillosis in haematological patients","volume":"64","author":"Viscoli","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2015.04.023_bib52","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1038\/bmt.2009.334","article-title":"Caspofungin first-line therapy for invasive aspergillosis in allogeneic hematopoietic stem cell transplant patients: an European Organisation for Research and Treatment of Cancer study","volume":"45","author":"Herbrecht","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jinf.2015.04.023_bib53","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1586\/14787210.2013.826989","article-title":"Therapeutic drug monitoring of voriconazole and posaconazole for invasive aspergillosis","volume":"11","author":"Seyedmousavi","year":"2013","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.jinf.2015.04.023_bib54","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1093\/jac\/dkt508","article-title":"Therapeutic drug monitoring of antifungal agents: guidelines from the British Society for Medical Mycology","volume":"69","author":"Ashbee","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2015.04.023_bib55","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1093\/jac\/dku053","article-title":"Evaluation of antifungal use in a tertiary care institution: antifungal stewardship urgently needed","volume":"69","author":"Valerio","year":"2014","journal-title":"J Antimicrob Chemother"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445315001164?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445315001164?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:21:06Z","timestamp":1759008066000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445315001164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":55,"alternative-id":["S0163445315001164"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2015.04.023","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Azole-resistant aspergillosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2015.04.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The British Infection Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}